New hope for mastocytosis patients through expanded drug access
NCT ID NCT06915766
Summary
This program provides access to the investigational drug bezuclastinib for adults with systemic mastocytosis, a rare disorder where too many mast cells build up in the body. It is for patients whose current treatments are not working well or who have no other good treatment options. The goal is to help control the disease in people who have already tried and failed at least one standard approved therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC MASTOCYTOSES, INDOLENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AIR Care
AVAILABLEDallas, Texas, 75231, United States
Contact Email: •••••@•••••
-
AllerVie Health
AVAILABLEGlenn Dale, Maryland, 20769, United States
Contact Email: •••••@•••••
-
Boston Specialists
AVAILABLEBoston, Massachusetts, 02111, United States
Contact Email: •••••@•••••
-
Dana Farber Cancer Institute
AVAILABLEBoston, Massachusetts, 02215, United States
Contact Email: •••••@•••••
-
Dartmouth-Hitchcock Medical Center
AVAILABLELebanon, New Hampshire, 03756, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Duke Blood Cancer Center
AVAILABLEDurham, North Carolina, 27705, United States
Contact Email: •••••@•••••
-
Indiana University Health
AVAILABLEIndianapolis, Indiana, 46202, United States
Contact Email: •••••@•••••
-
Mayo Clinic
AVAILABLERochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Memorial Sloan Kettering Cancer Center
AVAILABLENew York, New York, 10065, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Michigan Medicine- University of Michigan
AVAILABLEAnn Arbor, Michigan, 48109, United States
Contact Email: •••••@•••••
-
Orso Health/Modena Asthma Allergy
AVAILABLELa Jolla, California, 92037, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Scripps Green Hospital
AVAILABLELa Jolla, California, 92037, United States
Contact Email: •••••@•••••
-
Sneeze Wheeze & Itch Associates LLC Clinical Research Center
AVAILABLENormal, Illinois, 61761, United States
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-••••
-
Texas Children's Hospital
AVAILABLEHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Ohio State University Wexner Medical Center
AVAILABLEColumbus, Ohio, 43210, United States
Contact Email: •••••@•••••
-
The University of Texas, MD Anderson Cancer Center
AVAILABLEHouston, Texas, 77030, United States
Contact Email: •••••@•••••
-
UCLA Ronald Reagan Medical Center
AVAILABLELos Angeles, California, 90095, United States
Contact Phone: •••-•••-••••
Contact Email: •••••@•••••
-
Walter Reed
AVAILABLEBethesda, Maryland, 20889, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.